Training Example: TIVICAY (ViiV Healthcare) – Review the Data, Give Your Score & Compare to the Real AI Evaluation

Industry Context — Common BS Fingerprints in Medical Devices, Pharma & Biotech
Generic Claims: advancing human health, breakthrough innovation, life-changing therapies, transforming patient outcomes…
Red Flags: FDA cleared used interchangeably with FDA approved, clinical claims without published study citations, breakthrough claims for incremental improvements, regulatory status implied but not specified…
Semantic Drift Patterns: homepage claims breakthrough but pipeline page shows preclinical only, FDA approved claims but only for one indication, marketed broadly, claims clinical evidence but links to poster presentations not published studies, claims global reach but regulatory approvals are single-market…
Proof Expectations: specific regulatory clearance numbers (FDA 510(k), CE, TGA), published clinical trial results with ClinicalTrials.gov registration, ISO 13485 and GMP certification details, peer-reviewed publication citations…

TIVICAY (ViiV Healthcare)

(https://tivicay.com) 📸 Data Snapshot: June 19, 2026

Analyze the raw signals below. How would a machine score this business’s credibility?

Here are the exact signals captured from up to six pages of the site — the same raw inputs the evaluation engine analyzed. They are grouped by signal type so you can weigh each the way the machine does.

🏗️ Semantic Structure — heading hierarchy & page identity (Info Density · Commodity Fingerprint)
HOMEPAGE A Treatment Option | TIVICAY (dolutegravir) (https://tivicay.com)
Title

A Treatment Option | TIVICAY (dolutegravir)

Meta

Learn more about TIVICAY (dolutegravir). See if TIVICAY could be right for you.

H1 What is TIVICAY?
H2 You are now leaving this site
H2 ANOTHER TREATMENT OPTION MAY BE RIGHT FOR YOU.
📝 The Narrative — clean text per page (Info Density · Semantic Coherence)
HOMEPAGE · THIN (https://tivicay.com) A Treatment Option | TIVICAY (dolutegravir)
[H1] What is TIVICAY?

TIVICAY is a pill and contains dolutegravir.

TIVICAY is also available as tablets for oral suspension: TIVICAY PD.

View the Patient Information with Important Warnings.

ViiVConnect Savings Card and Support
Find out if you can get help paying for TIVICAY or TIVICAY PD

[H2] ANOTHER TREATMENT OPTION MAY BE RIGHT FOR YOU.

LEARN MORE
Trademarks are owned by or licensed to the ViiV Healthcare group of companies.
©2025 ViiV Healthcare or licensor.
NPUS-HVUWCNT250001 February 2025
Produced in USA.
613 chars
🛡️ Trust Signals — reviews, proof links, trust-theatre flag (Trust & Proof)
0Review mentions (all pages)
0External proof links (all pages)
PageReviewsProof links
/ (home) 0 0
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps (Identity & Authority)
Homepage — no schema detected (entity gap)

Your Diagnosis

Before revealing the machine’s verdict, predict the BS score for each signal. Higher = more BS (more fluff, less verifiable substance). Drag each slider, then submit to compare your judgment against the engine.

Information Density 0 / 30
Read the Narrative & headings: do hard facts (prices, dates, numbers) outweigh fluff power-words?
Semantic Coherence 0 / 20
Compare the homepage promise against the sub-page reality. Do they hold the same line?
Trust & Proof 0 / 20
Weigh review mentions against actual external proof links. Claims without verification = theatre.
Commodity Fingerprint 0 / 15
Check headings & narrative against the industry clichés in the setup above.
Identity & Authority 0 / 15
Inspect the schema: is there real Organization/Person identity with sameAs links, or gaps?
Your predicted BS score 0 / 100
💡 Stuck? Reveal the heuristic lens — how the deterministic page-auditor reads each signal (no AI, pure pattern rules)

These are the structural rules a local, deterministic auditor applies — the same lens you can use to judge each signal. They describe what to look for, not this company’s result.

Information Density

Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.

Semantic Alignment

Pull the main entities out of the H1, then check whether they actually recur through the body. A page that announces one thing and then talks about another drifts. Headings with no real sentences underneath read as pseudo-substance.

Trust & Proof

Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.

Commodity Fingerprint

Look at how much sentence length varies. Natural writing varies its rhythm; templated or mass-produced copy is statistically uniform. Very low variation reads as commodity content — unless unique named entities break the pattern.

Identity & Authority

Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.

Want to apply this lens yourself? The free BS Indicator Chrome extension runs these heuristic checks live on any page. Bear in mind it is a single-page, deterministic tool — it relies only on pattern rules for the page in front of it and does not perform the cross-page semantic correlation this audit uses, so its readout is a starting lens, not the full verdict.

B
BS Level
Medical Devices, Pharma & Biotech
40.7 Avg BS

Based on 784 businesses audited.

BS Detector

Medical Devices, Pharma & Biotech BS: TIVICAY (ViiV Healthcare) (tivicay.com)

https://tivicay.com 📍 Industry: Medical Devices, Pharma & Biotech
52 BS / 100

This is a regulatory placeholder disguised as a brand site. It provides the absolute legal minimum of information, functioning as a gateway to PDFs rather than a source of clinical truth. While it avoids traditional marketing fluff, its ‘substance’ is purely administrative, resulting in a moderate-to-high BS score due to the total absence of verifiable clinical proof on-page.

Info Density Power-words vs. Substance ratio.
13
43% BS
Semantic Coherence Homepage promise vs. Sub-page reality.
8
40% BS
Trust & Proof Verifiable evidence vs. Trust Theatre.
10
50% BS
Commodity Fingerprint Detection of industry clichés/templates.
9
60% BS
Identity & Authority Expert verifiability & Schema depth.
12
80% BS

Immediately implement Organization and Product schema to link the site to ViiV Healthcare’s official entity and FDA filings. Replace the generic H2 ‘ANOTHER TREATMENT OPTION MAY BE RIGHT FOR YOU’ with a specific, data-backed indication for use. Include at least three specific data points from clinical trials (e.g., viral suppression rates) directly in the body text. Add direct outbound links to peer-reviewed studies or the ClinicalTrials.gov entry to provide a clear proof path.

The site content confirms a precise match for the Pharmaceuticals category, specifically focusing on the drug dolutegravir. The presence of regulatory codes like NPUS-HVUWCNT250001 and references to ViiV Healthcare align with industry standards.

“The score of 52 is driven primarily by the technical and content gaps in Authority (12) and Information Density (13). The 'insufficient' nature of the crawl data highlights a site that is a 'shell'—it makes a primary signal as a medical resource but provides no evidence or structured data to support that role. The lack of any verifiable proof links or specific outcomes prevents the score from being lower.”

Verified Analysis Date: June 19, 2026 © 1EuroSEO Independent Evaluator — Non-Sponsored Result